Importer of Controlled Substances Application: Cardinal Health, 53116-53117 [2021-20760]
Download as PDF
<![CDATA[
53116
Federal Register / Vol. 86, No. 183 / Friday, September 24, 2021 / Notices
Sec. 31, those portions of the E1⁄2 lying
southeasterly of the southeasterly rightof-way boundary of State Route 604,
excepting CC–0360;
Sec. 32, those portions lying southeasterly
of the southeasterly right-of-way
boundary of State Route 604;
Secs. 33 thru 36.
T. 25 S., R. 60 E., those portions lying
southeasterly of the southeasterly rightof-way boundary of State Route 604,
excepting CC–0360.
T. 26 S., R. 60 E.,
Secs. 1 thru 24 and secs. 27 thru 34.
T. 27 S., R. 60 E.,
Secs. 3 thru 10 and secs. 13 thru 24.
T. 24 S., R. 61 E.,
Secs. 16 thru 21 and secs. 28 thru 33.
T. 25 S., R. 61 E.,
Secs. 4 thru 9, secs. 16 thru 21, and secs.
28 thru 33.
T. 26 S., R. 61 E.,
Secs. 6 and 7;
Sec. 8, SW1⁄4NW1⁄4 and NW1⁄4SW1⁄4,
excepting those portions affected by
Public Law 107–282.
The area described contains
approximately 106,786 acres, according
to the BLM National Public Land Survey
System and the official plats of the
surveys of the said land, on file with the
BLM.
Roads leading into the public lands
under the temporary closure will be
posted to notify the public of the
closure. The closure area includes the
Jean Dry Lake Bed and is bordered by
Hidden Valley to the north, the
McCullough Mountains to the east, the
California State line to the south and
Nevada State Route 604 to the west.
Under the authority of Section 303(a) of
the Federal Lands Policy and
Management Act of 1976 (43 U.S.C.
1733(a)), 43 CFR 8360.0–7, and 43 CFR
8364.1, the BLM will enforce the
following rules in the area described
above:
The entire area as listed in the legal
description above is closed to all
vehicles and personnel except law
enforcement, emergency vehicles, event
personnel, event participants, and
ticketed spectators. Access routes
leading to the closed area are closed to
vehicles. No vehicle stopping or parking
in the closed area except for designated
areas will be permitted. Event
participants and spectators are required
to remain within designated pit and
spectator areas only.
The following restrictions will be in
effect for the duration of the closure to
ensure safety of participants and
spectators. Unless otherwise authorized,
the following activities within the
closure area are prohibited:
• Camping.
• Possession and/or consuming any
alcoholic beverage unless the person has
reached the age of 21 years.
VerDate Sep<11>2014
16:50 Sep 23, 2021
Jkt 253001
• Discharging, or use of firearms or
other weapons.
• Possession and/or discharging of
fireworks.
• Allowing any pet or other animal in
the person’s care to be unrestrained at
any time. Animals must be on a leash
or other restraint no longer than 3 feet.
• Operation of any vehicle that is not
legally registered for street and highway
operation, for example, All Terrain
Vehicles (ATV), motorcycles, Utility
Terrain Vehicles (UTV), golf carts, and
any OHV, including operation of such a
vehicle in spectator viewing areas.
• Parking any vehicle in violation of
posted restrictions, or in such a manner
as to obstruct or impede normal or
emergency traffic movement or the
parking of other vehicles, create a safety
hazard, or endanger any person,
property, or feature. Vehicles so parked
are subject to citation, removal, and
impoundment at the owner’s expense.
• Operating a vehicle through,
around, or beyond a restrictive sign,
barricade, fence, or traffic control barrier
or device.
• Failing to maintain control of a
vehicle to avoid danger to persons,
property, resources, or wildlife.
• Operating a motor vehicle without
due care or at a speed greater than 25
mph.
Signs and maps directing the public
to designated spectator areas will be
provided by the event sponsor.
Exceptions: Temporary closure
restrictions do not apply to activities
conducted under contract with the
BLM, agency personnel monitoring the
event, or activities conducted under an
approved plan of operation. Authorized
users must have in their possession a
written permit or contract from the BLM
signed by the authorized officer.
Enforcement: Any person who
violates this temporary closure may be
tried before a United States Magistrate
and fined in accordance with 18 U.S.C.
3571, imprisoned no more than 12
months under 43 U.S.C. 1733(a) and 43
CFR 8360.0–7, or both. In accordance
with 43 CFR 8365.1–7, State or local
officials may also impose penalties for
violations of Nevada law.
(Authority: 43 CFR 8360.0–7 and 8364.1)
Shonna Dooman,
Field Manager, Las Vegas Field Office.
[FR Doc. 2021–20721 Filed 9–23–21; 8:45 am]
BILLING CODE 4310–HC–P
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–895]
Importer of Controlled Substances
Application: Cardinal Health
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Cardinal Health has applied
to be registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplemental Information
listed below for further drug
information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 25, 2021. Such
persons may also file a written request
for a hearing on the application on or
before October 25, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on July 22, 2021, Cardinal
Health, 15 Ingram Boulevard, La Vergne,
Tennessee 37086–3630, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
SUMMARY:
Controlled
substance
Secobarbital ......
Nabilone ...........
Drug code
2315
7379
Schedule
II
II
The company plans to import the
above controlled substance in finished
dosage form for distribution to licensed
registrants for the purpose of medical
use only. No other activity for these
drug codes is authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
E:\FR\FM\24SEN1.SGM
24SEN1
Federal Register / Vol. 86, No. 183 / Friday, September 24, 2021 / Notices
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; PermitRequired Confined Spaces
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–20760 Filed 9–23–21; 8:45 am]
BILLING CODE P
Notice of availability; request
for comments.
ACTION:
DEPARTMENT OF JUSTICE
[Docket No. DEA–896]
Bulk Manufacturer of Controlled
Substances Application: PCI Synthesis
Drug Enforcement
Administration, Justice.
AGENCY:
Notice of application.
PCI Synthesis has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 23, 2021. Such
persons may also file a written request
for a hearing on the application on or
before November 23, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on March 30, 2021, PCI
Synthesis, 9 Opportunity Way,
Newburyport, Massachusetts 01950–
0195, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
Amphetamine ...............
Methamphetamine ........
I
Schedule
1100
1105
II
III
The company plans to develop
manufacturing processes, conduct
analytical method validation and
conduct bulk product stability studies.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–20762 Filed 9–23–21; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
16:50 Sep 23, 2021
The Department of Labor
(DOL) is submitting this Occupational
Safety and Health Administration
(OSHA)-sponsored information
collection request (ICR) to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995
(PRA). Public comments on the ICR are
invited.
DATES: The OMB will consider all
written comments that agency receives
on or before October 25, 2021.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
Comments are invited on: (1) Whether
the collection of information is
necessary for the proper performance of
the functions of the Department,
including whether the information will
have practical utility; (2) if the
information will be processed and used
in a timely manner; (3) the accuracy of
the agency’s estimates of the burden and
cost of the collection of information,
including the validity of the
methodology and assumptions used; (4)
ways to enhance the quality, utility and
clarity of the information collection; and
(5) ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
automated collection techniques or
other forms of information technology.
FOR FURTHER INFORMATION CONTACT:
Crystal Rennie by telephone at 202–
693–0456 or by email at DOL_PRA_
PUBLIC@dol.gov.
SUPPLEMENTARY INFORMATION: The
collections of information are needed by
employers and employees involved in
the entry of permit-required confined
spaces to prevent injuries and death
from exposure to the hazards associated
with such entries. For additional
substantive information about this ICR,
see the related notice published in the
Federal Register on June 23, 2021 (86
FR 32978).
This information collection is subject
to the PRA. A Federal agency generally
SUMMARY:
Drug Enforcement Administration
ACTION:
DEPARTMENT OF LABOR
Jkt 253001
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
53117
cannot conduct or sponsor a collection
of information, and the public is
generally not required to respond to an
information collection, unless the OMB
approves it and displays a currently
valid OMB Control Number. In addition,
notwithstanding any other provisions of
law, no person shall generally be subject
to penalty for failing to comply with a
collection of information that does not
display a valid OMB Control Number.
See 5 CFR 1320.5(a) and 1320.6.
DOL seeks PRA authorization for this
information collection for three (3)
years. OMB authorization for an ICR
cannot be for more than three (3) years
without renewal. The DOL notes that
information collection requirements
submitted to the OMB for existing ICRs
receive a month-to-month extension
while they undergo review.
Agency: DOL–OSHA.
Title of Collection: Permit-Required
Confined Spaces.
OMB Control Number: 1218–0203.
Affected Public: Private Sector:
Businesses or other for-profits.
Total Estimated Number of
Respondents: 214,994.
Total Estimated Number of
Responses: 13,959,314.
Total Estimated Annual Time Burden:
2,076,039 hours.
Total Estimated Annual Other Costs
Burden: $645,000.
Authority: 44 U.S.C. 3507(a)(1)(D).
Crystal Rennie,
Senior PRA Analyst.
[FR Doc. 2021–20729 Filed 9–23–21; 8:45 am]
BILLING CODE 4510–26–P
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice: (21–061)]
Planetary Science Advisory
Committee; Meeting
National Aeronautics and
Space Administration.
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, as
amended, the National Aeronautics and
Space Administration (NASA)
announces a meeting of the Planetary
Science Advisory Committee. The
meeting will be held for the purpose of
soliciting, from the scientific
community and other persons, scientific
and technical information relevant to
program planning.
DATES: Monday, October 18, 2021, 10:00
a.m. to 6:00 p.m., Eastern Time; and
Tuesday, October 19, 2021, 10:00 a.m. to
6:00 p.m., Eastern Time
SUMMARY:
E:\FR\FM\24SEN1.SGM
24SEN1
]]>Agencies
[Federal Register Volume 86, Number 183 (Friday, September 24, 2021)]
[Notices]
[Pages 53116-53117]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20760]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-895]
Importer of Controlled Substances Application: Cardinal Health
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Cardinal Health has applied to be registered as an importer of
basic class(es) of controlled substance(s). Refer to Supplemental
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before October 25,
2021. Such persons may also file a written request for a hearing on the
application on or before October 25, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on July 22, 2021, Cardinal Health, 15 Ingram Boulevard,
La Vergne, Tennessee 37086-3630, applied to be registered as an
importer of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Secobarbital....................... 2315 II
Nabilone........................... 7379 II
------------------------------------------------------------------------
The company plans to import the above controlled substance in
finished dosage form for distribution to licensed registrants for the
purpose of medical use only. No other activity for these drug codes is
authorized for this registration.
Approval of permit applications will occur only when the
registrant's
[[Page 53117]]
business activity is consistent with what is authorized under 21 U.S.C.
952(a)(2).
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-20760 Filed 9-23-21; 8:45 am]
BILLING CODE P
